Evidence map›Paper›PMID 40538444›Full record

ArticleBioinformatics advances2025

NRGSuite-Qt: a PyMOL plugin for high-throughput virtual screening, molecular docking, normal-mode analysis, the study of molecular interactions, and the detection of binding-site similarities.

Gabriel Tiago Galdino, Thomas DesCôteaux, Natalia Teruel, Rafael Najmanovich

Abstract read
In one paragraph

Article in Bioinformatics advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Gabriel Tiago GaldinoDepartment of Pharmacology and Physiology, Université de Montréal, Montréal, QC H3C 3J7, Canada.ORCID https://orcid.org/0000-0001-6436-6026
Thomas DesCôteauxDepartment of Pharmacology and Physiology, Université de Montréal, Montréal, QC H3C 3J7, Canada.ORCID https://orcid.org/0009-0003-1810-4318
Natalia TeruelDepartment of Pharmacology and Physiology, Université de Montréal, Montréal, QC H3C 3J7, Canada.ORCID https://orcid.org/0000-0003-3485-973X
Rafael NajmanovichDepartment of Pharmacology and Physiology, Université de Montréal, Montréal, QC H3C 3J7, Canada.ORCID https://orcid.org/0000-0002-6971-7224

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Summary: We introduce NRGSuite-Qt, a PyMOL plugin, that provides a comprehensive toolkit for macromolecular cavity detection, virtual screening, small-molecule docking, normal mode analysis, analyses of molecular interactions, and detection of binding-site similarities. This complete redesign of the original NRGSuite (restricted to cavity detection and small-molecule docking) integrates five new functionalities: protein-protein and protein-ligand interaction analysis using Surfaces, ultra-massive virtual screening with NRGRank, binding-site similarity detection with IsoMIF, normal mode analysis using NRGTEN, and mutational studies through integration with the Modeler Suite. By merging these advanced tools into a cohesive platform, NRGSuite-Qt simplifies visualization and streamlines complex workflows within a single interface. Additionally, we benchmark a newer version of the Elastic Network Contact Model (ENCoM) for normal mode analysis method, utilizing the same 40 atom-type pairwise interaction matrix that is used in all other software. This version outperforms the default model in multiple benchmarking tests. Avalilability and implementation: The Installation guide and tutorial is available at https://nrg-qt.readthedocs.io/en/latest/index.html. The NRGSuite-Qt is implement in Python.

Identifiers

PMID40538444
PMCPMC12177131

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.